Expression of POEM, a positive regulator of osteoblast differentiation, is suppressed by TNF-α

Biochemical and Biophysical Research Communications

Volumn 410, Issue 4, 2011, Pages 766-770

  Tsukasaki, Masayuki ^a   Yamada, Atsushi ^a   Suzuki, Dai ^a   Aizawa, Ryo ^a   Miyazono, Agasa ^a   Miyamoto, Yoichi ^a   Suzawa, Tetsuo ^a   Takami, Masamichi ^a   Yoshimura, Kentaro ^a   Morimura, Naoko ^b   Yamamoto, Matsuo ^a   Kamijo, Ryutaro ^a  

^a SHOWA UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

NF B; Osteoblasts; POEM; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEPHRONECTIN; SCLEROPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DOWN REGULATION; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; NF-KAPPA B; OSTEOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960305326     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.048     Document Type: Article

References (26)

1. Brandenberger R., Schmidt A., Linton J., Wang D., Backus C., Denda S., Muller U., Reichardt L.F. Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J. Cell Biol. 2001, 154:447-458.
2. Morimura N., Tezuka Y., Watanabe N., Yasuda M., Miyatani S., Hozumi N., Tezuka Ki K. Molecular cloning of POEM: a novel adhesion molecule that interacts with alpha8beta1 integrin. J. Biol. Chem. 2001, 276:42172-42181.
3. Miyazono A., Yamada A., Morimura N., Takami M., Suzuki D., Kobayashi M., Tezuka K., Yamamoto M., Kamijo R. TGF-beta suppresses POEM expression through ERK1/2 and JNK in osteoblasts. FEBS Lett. 2007, 581:5321-5326.
4. Linton J.M., Martin G.R., Reichardt L.F. The ECM protein nephronectin promotes kidney development via integrin alpha8beta1-mediated stimulation of Gdnf expression. Development 2007, 134:2501-2509.
5. Fujiwara H., Ferreira M., Donati G., Marciano D.K., Linton J.M., Sato Y., Hartner A., Sekiguchi K., Reichardt L.F., Watt F.M. The basement membrane of hair follicle stem cells is a muscle cell niche. Cell 2011, 144:577-589.
6. Bradley J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214:149-160.
7. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
8. Yamazaki M., Fukushima H., Shin M., Katagiri T., Doi T., Takahashi T., Jimi E. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J. Biol. Chem. 2009, 284:35987-35995.
9. David J.P., Schett G. TNF and bone. Curr. Dir. Autoimmun. 2010, 11:135-144.
10. Karin M., Gallagher E. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol. Rev. 2009, 228:225-240.
11. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., Nanes M.S. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000, 141:3956-3964.
12. Kahai S., Lee S.C., Seth A., Yang B.B. Nephronectin promotes osteoblast differentiation via the epidermal growth factor-like repeats. FEBS Lett. 2010, 584:233-238.
13. Kahai S., Lee S.C., Lee D.Y., Yang J., Li M., Wang C.H., Jiang Z., Zhang Y., Peng C., Yang B.B. MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS ONE 2009, 4:e7535.
14. Fang L., Kahai S., Yang W., He C., Seth A., Peng C., Yang B.B. Transforming growth factor-beta inhibits nephronectin-induced osteoblast differentiation. FEBS Lett. 2010, 584:2877-2882.
15. Yasuhara R., Suzawa T., Miyamoto Y., Wang X., Takami M., Yamada A., Kamijo R. Nitric oxide in pulp cell growth, differentiation, and mineralization. J. Dent. Res. 2007, 86:163-168.
16. Zhao B., Katagiri T., Toyoda H., Takada T., Yanai T., Fukuda T., Chung U.I., Koike T., Takaoka K., Kamijo R. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 2006, 281:23246-23253.
17. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 1983, 96:191-198.
18. Majewski P.M., Thurston R.D., Ramalingam R., Kiela P.R., Ghishan F.K. Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblasts. J. Biol. Chem. 2010, 285:34828-34838.
19. Aoki T., Kataoka H., Ishibashi R., Nozaki K., Morishita R., Hashimoto N. Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1080-1086.
20. Li Y., Li A., Strait K., Zhang H., Nanes M.S., Weitzmann M.N. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J. Bone Miner. Res. 2007, 22:646-655.
21. Marcu K.B., Otero M., Olivotto E., Borzi R.M., Goldring M.B. NF-kappaB signaling: multiple angles to target OA. Curr. Drug Targets 2010, 11:599-613.
22. Goltzman D. Vitamin D action: lessons learned from genetic mouse models. Ann. N. Y. Acad. Sci. 2010, 1192:145-152.
23. Lu X., Farmer P., Rubin J., Nanes M.S. Integration of the NFkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J. Cell. Biochem. 2004, 92:833-848.
24. Rameshwar P., Narayanan R., Qian J., Denny T.N., Colon C., Gascon P. NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J. Immunol. 2000, 165:2271-2277.
25. Nakase T., Takaoka K., Masuhara K., Shimizu K., Yoshikawa H., Ochi T. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 1997, 21:17-21.
26. Nanes M.S. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003, 321:1-15.